• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: M.I.TECH CO., LTD. HANAROSTENT?? ESOPHAGUS TTS (CCC)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

M.I.TECH CO., LTD. HANAROSTENT?? ESOPHAGUS TTS (CCC) Back to Search Results
Model Number ECBA-20-100-230
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/01/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is being submitted as an initial mdr by the manufacturer.The distributor also submitted a report reference no: (b)(4).Based on the description, this case involves the off-label use of an esophaseal stent in a duodenal procedure.Given this off-label use, we assume that the stent fracture occurred due to this inappropriate application of the product.Consequently, it is not possible to analyze the root cause base on the product's intended use.No further information is expected.The initial mdr submission was delayed because m.I.Tech was not aware that distributors had independently submitted mdrs, as several notifications were sent to an inactive email address and no internal process yet existed to routinely verify distributor-submitted reports.This gap has now been addressed through olympus staff retraining, initiation of a capa, and m.I.Tech's implementation of a regular review process to ensure timely identification of mdr-reportable events.
 
Event or Problem Description
Olympus sales representative (b)(4) reported the event on behalf of the treating physician, doctor (b)(6).According to the report, an esophageal stent was implanted in the patient's duodenum in (b)(6) 2024.The patient returned to the hospital in (b)(6) 2025, at which time a ct scan revealed that the implanted stent had fractured into two pieces, resulting in surgery to remedy the issue.The exact time point when the stent split into two pieces was not identified.
 
Additional Manufacturer Narrative
This follow-up report is intended to correct the coding terms that were either incorrectly entered or omitted in the previous report.This report is being submitted as an initial mdr by the manufacturer.The hospital also submitted a report (emdr-(b)(4), reference no: (b)(4).Based on the description, this case involves the off-label use of an esophaseal stent in a duodenal procedure.Given this off-label use, we assume that the stent fracture occurred due to this inappropriate application of the product.Consequently, it is not possible to analyze the root cause base on the product's intended use.
 
Event or Problem Description
It was reported that during a therapeutic stent removal for a duodenal stricture, the suspect device broke in half.The pieces were retrieved.The issue date was mentioned to be (b)(6) 2024.The device, esphageal stent, was placed in the duodenum of the patient.The patient returned to the hospital in (b)(6) 2025.A ct scan was completed and it was found that the implant had broken into two pieces, resulting in surgery to remedy the issue.No specific time was mentioned when the stent had split in 2 pieces.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANAROSTENT?? ESOPHAGUS TTS (CCC)
Common Device Name
HANAROSTENT?? ESOPHAGUS TTS (CCC)
Manufacturer (Section D)
M.I.TECH CO., LTD.
174 habuk 2-gil, jinwi-myeon
pyeongtaek, gyeonggi, 17706
KS  17706
Manufacturer Contact
taejun kwon
174 habuk 2-gil, jinwi-myeon
pyeongtaek, gyeonggi, 17706
KS   17706
MDR Report Key23775589
Report Number3008146331-2025-00005
Device Sequence Number10131354
Product Code ESW
UDI-Device Identifier08806367088529
UDI-Public08806367088529
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberECBA-20-100-230
Device Lot Number24101248
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date12/11/2025
Supplement Report FDA Received Date02/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-